{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:07:29Z","timestamp":1774080449962,"version":"3.50.1"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01705-x","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:17:05Z","timestamp":1772702225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoding the Glioblastoma Microenvironment: AI-Driven Analysis of Cellular MRI Signatures for Targeted Therapy"],"prefix":"10.1007","volume":"46","author":[{"given":"Yao","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiantao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"issue":"1","key":"1705_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac184","volume":"5","author":"AH Abayazeed","year":"2023","unstructured":"Abayazeed AH, Abbassy A, M\u00fceller M, Hill M, Qayati M, Mohamed S, Mekhaimar M, Raymond C, Dubey P, Nael K, Rohatgi S, Kapare V, Kulkarni A, Shiang T, Kumar A, Andratschke N, Willmann J, Brawanski A, De Jesus R, Tuna I, Fung SH, Landolfi JC, Ellingson BM, Reyes M (2023) NS-HGlio: a generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinics. Neuro-Oncol Adv 5(1):vdac184. https:\/\/doi.org\/10.1093\/noajnl\/vdac184","journal-title":"Neuro-Oncol Adv"},{"issue":"1","key":"1705_CR2","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/s41598-021-94560-3","volume":"11","author":"H Akbari","year":"2021","unstructured":"Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S (2021) Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging. Sci Rep 11(1):15011","journal-title":"Sci Rep"},{"issue":"4","key":"1705_CR3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3892\/mi.2024.164","volume":"4","author":"A Al-Rahbi","year":"2024","unstructured":"Al-Rahbi A, Omar Al-Mahrouqi, and, Tariq Al-Saadi (2024) Uses of artificial intelligence in glioma: A systematic review. Med Int 4(4):40","journal-title":"Med Int"},{"issue":"11","key":"1705_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14111066","volume":"14","author":"Y Barhoumi","year":"2024","unstructured":"Barhoumi Y, Fattah AH, Bouaynaya N, Moron F, Kim J, Fathallah-Shaykh HM, Chahine RA, Sotoudeh H (2024) Robust AI-driven segmentation of glioblastoma T1c and FLAIR MRI series and the low variability of the MRIMath\u00a9 smart manual contouring platform. Diagnostics 14(11):1066","journal-title":"Diagnostics"},{"key":"1705_CR5","volume-title":"Medical imaging 2017: computer-aided diagnosis","author":"N Beig","year":"2017","unstructured":"Beig N, Patel J, Prasanna P, Partovi S, Varadan V, Madabhushi A, Tiwari P (2017) Radiogenomic analysis of hypoxia pathway reveals computerized MRI descriptors predictive of overall survival in glioblastoma. Medical imaging 2017: computer-aided diagnosis. SPIE, Cergy Pontoise"},{"key":"1705_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14131374","author":"MJ Belue","year":"2024","unstructured":"Belue MJ, Harmon SA, Chappidi S, Zhuge Y, Tasci E, Jagasia S, Joyce T, Camphausen K, Turkbey B, Krauze AV (2024) Diagnosing progression in glioblastoma-tackling a neuro-oncology problem using artificial-intelligence-derived volumetric change over time on magnetic resonance imaging to examine progression-free survival in glioblastoma. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics14131374","journal-title":"Diagnostics"},{"issue":"5","key":"1705_CR7","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00234-023-03126-9","volume":"65","author":"A Bhandari","year":"2023","unstructured":"Bhandari A, Scott L, Weilbach M, Marwah R, Lasocki A (2023) Assessment of artificial intelligence (AI) reporting methodology in glioma MRI studies using the Checklist for AI in Medical Imaging (CLAIM). Neuroradiology 65(5):907\u2013913. https:\/\/doi.org\/10.1007\/s00234-023-03126-9","journal-title":"Neuroradiology"},{"issue":"1","key":"1705_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40708-023-00207-6","volume":"10","author":"A Bianconi","year":"2023","unstructured":"Bianconi A, Rossi LF, Bonada M, Zeppa P, Nico E, De Marco R, Lacroce P, Cofano F, Bruno F, Morana G (2023) Deep learning-based algorithm for postoperative glioblastoma MRI segmentation: a promising new tool for tumor burden assessment. Brain Inf 10(1):26","journal-title":"Brain Inf"},{"issue":"16","key":"1705_CR9","doi-asserted-by":"publisher","first-page":"7911","DOI":"10.7150\/thno.56639","volume":"11","author":"J Bolcaen","year":"2021","unstructured":"Bolcaen J, Kleynhans J, Nair S, Verhoeven J, Goethals I, Sathekge M, Vandevoorde C, Ebenhan T (2021) A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma. Theranostics 11(16):7911","journal-title":"Theranostics"},{"issue":"1","key":"1705_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.crad.2019.07.001","volume":"75","author":"TC Booth","year":"2020","unstructured":"Booth TC, Williams M, Luis A, Cardoso J, Ashkan K, Shuaib H (2020) Machine learning and glioma imaging biomarkers. Clin Radiol 75(1):20\u201332","journal-title":"Clin Radiol"},{"issue":"21","key":"1705_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15215241","volume":"15","author":"AL Breto","year":"2023","unstructured":"Breto AL, Cullison K, Zacharaki EI, Wallaengen V, Maziero D, Jones K, Valderrama A, de la Fuente MI, Meshman J, Azzam GA (2023) A deep learning approach for automatic segmentation during daily MRI-Linac radiotherapy of glioblastoma. Cancers 15(21):5241","journal-title":"Cancers"},{"issue":"1","key":"1705_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac060","volume":"4","author":"E Calabrese","year":"2022","unstructured":"Calabrese E, Rudie JD, Rauschecker AM, Villanueva-Meyer JE, Clarke JL, Solomon DA, Cha S (2022a) Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma. Neuro-Oncol Adv 4(1):vdac060. https:\/\/doi.org\/10.1093\/noajnl\/vdac060","journal-title":"Neuro-Oncol Adv"},{"issue":"1","key":"1705_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdac060","volume":"4","author":"E Calabrese","year":"2022","unstructured":"Calabrese E, Rudie JD, Rauschecker AM, Villanueva-Meyer JE, Clarke JL, Solomon DA, Cha S (2022b) Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma. Neuro-Oncol Adv 4(1):vdac060","journal-title":"Neuro-Oncol Adv"},{"issue":"3","key":"1705_CR14","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.3390\/curroncol30030203","volume":"30","author":"M C\u00e8","year":"2023","unstructured":"C\u00e8 M, Irmici G, Foschini C, Danesini GM, Falsitta LV, Serio ML, Fontana A, Martinenghi C, Oliva G, Cellina M (2023) Artificial intelligence in brain tumor imaging: a step toward personalized medicine. Current Oncology 30(3):2673\u20132701","journal-title":"Current Oncology"},{"issue":"1","key":"1705_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85400-9","volume":"15","author":"V Cerina","year":"2025","unstructured":"Cerina V, Rui CB, Di Cristofori A, Ferlito D, Carrabba G, Giussani C, Basso G, De Bernardi E (2025) Implication of tumor morphology and MRI characteristics on the accuracy of automated versus human segmentation of GBM areas. Sci Rep 15(1):2160","journal-title":"Sci Rep"},{"issue":"3","key":"1705_CR16","first-page":"475","volume":"27","author":"S Cha","year":"2006","unstructured":"Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27(3):475\u2013487","journal-title":"AJNR Am J Neuroradiol"},{"key":"1705_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.phrs.2019.02.027","volume":"142","author":"S Chatterjee","year":"2019","unstructured":"Chatterjee S, Sil PC (2019) Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy. Pharmacol Res 142:251\u2013261. https:\/\/doi.org\/10.1016\/j.phrs.2019.02.027","journal-title":"Pharmacol Res"},{"issue":"7412","key":"1705_CR18","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488(7412):522\u2013526. https:\/\/doi.org\/10.1038\/nature11287","journal-title":"Nature"},{"key":"1705_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205063","author":"EYW Cheung","year":"2023","unstructured":"Cheung EYW, Wu RWK, Li ASM, Chu ESM (2023) AI deployment on GBM diagnosis: a novel approach to analyze histopathological images using image feature-based analysis. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15205063","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1705_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2214\/AJR.17.18754","volume":"210","author":"D Chow","year":"2018","unstructured":"Chow D, Chang P, Weinberg BD, Bota DA, Grinband J, Filippi CG (2018) Imaging genetic heterogeneity in glioblastoma and other glial tumors: review of current methods and future directions. AJR Am J Roentgenol 210(1):30\u201338","journal-title":"AJR Am J Roentgenol"},{"key":"1705_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.703764","author":"A Comba","year":"2021","unstructured":"Comba A, Faisal SM, Varela ML, Hollon T, Al-Holou WN, Umemura Y, Nunez FJ, Motsch S, Castro MG, Lowenstein PR (2021a) Uncovering spatiotemporal heterogeneity of high-grade gliomas: from disease biology to therapeutic implications. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2021.703764","journal-title":"Front Oncol"},{"key":"1705_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.703764","volume":"11","author":"A Comba","year":"2021","unstructured":"Comba A, Faisal SM, Varela ML, Hollon T, Al-Holou WN, Umemura Y, Nunez FJ, Motsch S, Castro MG, Lowenstein PR (2021b) Uncovering spatiotemporal heterogeneity of high-grade gliomas: from disease biology to therapeutic implications. Front Oncol 11:703764","journal-title":"Front Oncol"},{"issue":"4","key":"1705_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14041092","volume":"14","author":"C-B Crivii","year":"2022","unstructured":"Crivii C-B, Bo\u0219ca AB, Melincovici CS, Constantin A-M, M\u0103rginean M, Dronca E, Sufle\u021bel R, Gonciar D, Bung\u0103rdean M, \u0218ovrea A (2022) Glioblastoma microenvironment and cellular interactions. Cancers 14(4):1092","journal-title":"Cancers"},{"issue":"14","key":"1705_CR24","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1158\/1078-0432.Ccr-23-0009","volume":"29","author":"LL de Godoy","year":"2023","unstructured":"de Godoy LL, Chawla S, Brem S, Mohan S (2023) Taming glioblastoma in \u201cReal Time\u201d: integrating multimodal advanced neuroimaging\/AI tools towards creating a robust and therapy agnostic model for response assessment in neuro-oncology. Clin Cancer Res 29(14):2588\u20132592. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-23-0009","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1705_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00789-2","volume":"9","author":"FJ Dorfner","year":"2025","unstructured":"Dorfner FJ, Patel JB, Kalpathy-Cramer J, Gerstner ER, Bridge CP (2025) A review of deep learning for brain tumor analysis in MRI. NPJ Precis Oncol 9(1):2","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"1705_CR26","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13632","volume":"25","author":"O El Atat","year":"2022","unstructured":"El Atat O, Naser R, Abdelkhalek M, Abi Habib R, El Sibai M (2022) Molecular targeted therapy: a new avenue in glioblastoma treatment. Oncol Lett 25(2):46","journal-title":"Oncol Lett"},{"issue":"8","key":"1705_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087047","volume":"24","author":"JI Erices","year":"2023","unstructured":"Erices JI, Bizama C, Niechi I, Uribe D, Rosales A, Fabres K, Navarro-Mart\u00ednez G, Torres \u00c1, San Mart\u00edn R, Roa JC (2023) Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets. International journal of molecular sciences 24(8):7047","journal-title":"International journal of molecular sciences"},{"issue":"1","key":"1705_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jmri.26907","volume":"52","author":"A Fathi Kazerooni","year":"2020","unstructured":"Fathi Kazerooni A, Bakas S, Saligheh Rad H, Davatzikos C (2020) Imaging signatures of glioblastoma molecular characteristics: a radiogenomics review. J Magn Reson Imaging 52(1):54\u201369","journal-title":"J Magn Reson Imaging"},{"key":"1705_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235921","author":"A Fathi Kazerooni","year":"2021","unstructured":"Fathi Kazerooni A, Bagley SJ, Akbari H, Saxena S, Bagheri S, Guo J, Chawla S, Nabavizadeh A, Mohan S, Bakas S, Davatzikos C, Nasrallah MP (2021a) Applications of radiomics and radiogenomics in high-grade gliomas in the era of precision medicine. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13235921","journal-title":"Cancers (Basel)"},{"issue":"23","key":"1705_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13235921","volume":"13","author":"A Fathi Kazerooni","year":"2021","unstructured":"Fathi Kazerooni A, Bagley SJ, Akbari H, Saxena S, Bagheri S, Guo J, Chawla S, Nabavizadeh A, Mohan S, Bakas S (2021b) Applications of radiomics and radiogenomics in high-grade gliomas in the era of precision medicine. Cancers 13(23):5921","journal-title":"Cancers"},{"issue":"1","key":"1705_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12699-z","volume":"12","author":"A Fathi Kazerooni","year":"2022","unstructured":"Fathi Kazerooni A, Saxena S, Toorens E, Tu D, Bashyam V, Akbari H, Mamourian E, Sako C, Koumenis C, Verginadis I (2022) Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastoma. Sci Rep 12(1):8784","journal-title":"Sci Rep"},{"issue":"7","key":"1705_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s11547-023-01655-0","volume":"128","author":"D Franco","year":"2023","unstructured":"Franco D, Granata V, Fusco R, Grassi R, Nardone V, Lombardi L, Cappabianca S, Conforti R, Briganti F, Grassi R, Caranci F (2023) Artificial intelligence and radiation effects on brain tissue in glioblastoma patient: preliminary data using a quantitative tool. Radiol Med 128(7):813\u2013827. https:\/\/doi.org\/10.1007\/s11547-023-01655-0","journal-title":"Radiol Med"},{"issue":"8","key":"1705_CR33","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1158\/1541-7786.MCR-23-0048","volume":"21","author":"LA Garcia-Montano","year":"2023","unstructured":"Garcia-Montano LA, Licon-Munoz Y, Martinez FJ, Keddari YR, Ziemke MK, Chohan MO, Piccirillo SG (2023) Dissecting intra-tumor heterogeneity in the glioblastoma microenvironment using fluorescence-guided multiple sampling. Mol Cancer Res 21(8):755\u2013767","journal-title":"Mol Cancer Res"},{"issue":"1","key":"1705_CR34","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","volume":"19","author":"D Hambardzumyan","year":"2016","unstructured":"Hambardzumyan D, Gutmann DH, Kettenmann H (2016) The role of microglia and macrophages in glioma maintenance and progression. Nat Neurosci 19(1):20\u201327. https:\/\/doi.org\/10.1038\/nn.4185","journal-title":"Nat Neurosci"},{"issue":"6","key":"1705_CR35","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2214\/ajr.19.22187","volume":"215","author":"BE Hamilton","year":"2020","unstructured":"Hamilton BE, Barajas R, Nesbit GM, Fu R, Ambady P, Taylor M, Neuwelt EA (2020) Ferumoxytol-enhanced MRI is not inferior to gadolinium-enhanced MRI in detecting intracranial metastatic disease and metastasis size. AJR Am J Roentgenol 215(6):1436\u20131442. https:\/\/doi.org\/10.2214\/ajr.19.22187","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"1705_CR36","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.ajpath.2012.06.030","volume":"181","author":"ME Hardee","year":"2012","unstructured":"Hardee ME, Zagzag D (2012) Mechanisms of glioma-associated neovascularization. Am J Pathol 181(4):1126\u20131141. https:\/\/doi.org\/10.1016\/j.ajpath.2012.06.030","journal-title":"Am J Pathol"},{"key":"1705_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10493-6","author":"DH Heiland","year":"2019","unstructured":"Heiland DH, Ravi VM, Behringer SP, Frenking JH, Wurm J, Joseph K, Garrelfs NWC, Str\u00e4hle J, Heynckes S, Grauvogel J, Franco P, Mader I, Schneider M, Potthoff A-L, Delev D, Hofmann UG, Fung C, Beck J, Sankowski R, Prinz M, Schnell O (2019) Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nature Commun. https:\/\/doi.org\/10.1038\/s41467-019-10493-6","journal-title":"Nature Commun"},{"issue":"1","key":"1705_CR38","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.2020190199","volume":"3","author":"KV Hoebel","year":"2021","unstructured":"Hoebel KV, Patel JB, Beers AL, Chang K, Singh P, Brown JM, Pinho MC, Batchelor TT, Gerstner ER, Rosen BR, Kalpathy-Cramer J (2021) Radiomics repeatability pitfalls in a scan-rescan MRI study of glioblastoma. Radiol: Artif Intell 3(1):e190199. https:\/\/doi.org\/10.1148\/ryai.2020190199","journal-title":"Radiol: Artif Intell"},{"key":"1705_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1134109","volume":"13","author":"GW Hooper","year":"2023","unstructured":"Hooper GW, Ginat DT (2023) MRI radiomics and potential applications to glioblastoma. Front Oncol 13:1134109. https:\/\/doi.org\/10.3389\/fonc.2023.1134109","journal-title":"Front Oncol"},{"issue":"2","key":"1705_CR40","first-page":"37","volume":"3","author":"SF Hossain","year":"2023","unstructured":"Hossain SF, Amin MA, Liza IA, Ahmed S, Haque MM, Islam MA, Akter S (2023) AI-based brain MRI segmentation for early diagnosis and treatment planning of low-grade gliomas in the USA. Br J Nurs 3(2):37\u201355","journal-title":"Br J Nurs"},{"key":"1705_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14080448","author":"KL Hsieh","year":"2024","unstructured":"Hsieh KL, Chen Q, Salzillo TC, Zhang J, Jiang X, Bhattacharya PK, Shams S (2024) Hyperpolarized magnetic resonance imaging, nuclear magnetic resonance metabolomics, and artificial intelligence to interrogate the metabolic evolution of glioblastoma. Metabolites. https:\/\/doi.org\/10.3390\/metabo14080448","journal-title":"Metabolites"},{"key":"1705_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146679","author":"M Huang","year":"2025","unstructured":"Huang M, Law HKW, Tam SY (2025) Use of radiomics in characterizing tumor hypoxia. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26146679","journal-title":"Int J Mol Sci"},{"key":"1705_CR43","doi-asserted-by":"publisher","DOI":"10.1177\/20552076251332018","volume":"11","author":"MS Iqbal","year":"2025","unstructured":"Iqbal MS, Bajwa UI, Raza R, Anwar MW (2025) Integrated brain tumor segmentation and MGMT promoter methylation status classification from multimodal MRI data using deep learning. Digit Health 11:20552076251332018. https:\/\/doi.org\/10.1177\/20552076251332018","journal-title":"Digit Health"},{"key":"1705_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.compmedimag.2021.101906","volume":"91","author":"M Islam","year":"2021","unstructured":"Islam M, Wijethilake N, Ren H (2021) Glioblastoma multiforme prognosis: MRI missing modality generation, segmentation and radiogenomic survival prediction. Comput Med Imaging Graph 91:101906. https:\/\/doi.org\/10.1016\/j.compmedimag.2021.101906","journal-title":"Comput Med Imaging Graph"},{"key":"1705_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jconrel.2020.01.009","volume":"320","author":"LL Israel","year":"2020","unstructured":"Israel LL, Galstyan A, Holler E, Ljubimova JY (2020) Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain. J Control Release 320:45\u201362. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.009","journal-title":"J Control Release"},{"key":"1705_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci15060576","author":"K Jang","year":"2025","unstructured":"Jang K, Back M (2025) Spatial mapping of glioblastoma infiltration: diffusion tensor imaging-based radiomics and connectomics in recurrence prediction. Brain Sciences. https:\/\/doi.org\/10.3390\/brainsci15060576","journal-title":"Brain Sciences"},{"issue":"1","key":"1705_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00575-0","volume":"8","author":"S Khalighi","year":"2024","unstructured":"Khalighi S, Reddy K, Midya A, Pandav KB, Madabhushi A, Abedalthagafi M (2024) Artificial intelligence in neuro-oncology: advances and challenges in brain tumor diagnosis, prognosis, and precision treatment. NPJ Precis Oncol 8(1):80","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"1705_CR48","doi-asserted-by":"publisher","first-page":"e120638","DOI":"10.5812\/ijcm.120638","volume":"15","author":"Z Khazaee","year":"2022","unstructured":"Khazaee Z, Langarizadeh M, Ahmadabadi MES (2022) Developing an artificial intelligence model for tumor gradingclassification, based on MRI sequences of human brain gliomas. Int J Cancer Manag 15(1):e120638","journal-title":"Int J Cancer Manag"},{"key":"1705_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.789355","volume":"13","author":"M Kumar","year":"2022","unstructured":"Kumar M, Nanga RPR, Verma G, Wilson N, Brisset JC, Nath K, Chawla S (2022) Emerging MR imaging and spectroscopic methods to study brain tumor metabolism. Front Neurol 13:789355","journal-title":"Front Neurol"},{"issue":"1","key":"1705_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43715-5","volume":"13","author":"R Kushol","year":"2023","unstructured":"Kushol R, Parnianpour P, Wilman AH, Kalra S, Yang YH (2023) Effects of MRI scanner manufacturers in classification tasks with deep learning models. Sci Rep 13(1):16791. https:\/\/doi.org\/10.1038\/s41598-023-43715-5","journal-title":"Sci Rep"},{"key":"1705_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.592389","volume":"11","author":"D Li","year":"2020","unstructured":"Li D, Patel CB, Xu G, Iagaru A, Zhu Z, Zhang L, Cheng Z (2020) Visualization of diagnostic and therapeutic targets in glioma with molecular imaging. Front Immunol 11:592389","journal-title":"Front Immunol"},{"issue":"6","key":"1705_CR52","doi-asserted-by":"publisher","first-page":"4375","DOI":"10.1111\/jcmm.14328","volume":"23","author":"X Liao","year":"2019","unstructured":"Liao X, Cai B, Tian B, Luo Y, Song W, Li Y (2019) Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time. J Cell Mol Med 23(6):4375\u20134385. https:\/\/doi.org\/10.1111\/jcmm.14328","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1705_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01544-7","volume":"17","author":"H Lin","year":"2024","unstructured":"Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y (2024) Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives. J Hematol Oncol 17(1):31","journal-title":"J Hematol Oncol"},{"key":"1705_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.artmed.2024.102776","volume":"148","author":"H Liu","year":"2024","unstructured":"Liu H, Huang J, Li Q, Guan X, Tseng M (2024) A deep convolutional neural network for the automatic segmentation of glioblastoma brain tumor: joint spatial pyramid module and attention mechanism network. Artif Intell Med 148:102776. https:\/\/doi.org\/10.1016\/j.artmed.2024.102776","journal-title":"Artif Intell Med"},{"issue":"2","key":"1705_CR55","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14599","volume":"30","author":"X Liu","year":"2024","unstructured":"Liu X, Liu L, Wu A, Huang S, Xu Z, Zhang X, Li Z, Li H, Dong J (2024b) Transformed astrocytes confer temozolomide resistance on glioblastoma via delivering ALKBH7 to enhance APNG expression after educating by glioblastoma stem cells-derived exosomes. CNS Neurosci Ther 30(2):e14599. https:\/\/doi.org\/10.1111\/cns.14599","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"1705_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-025-01221-7","volume":"12","author":"J Liu","year":"2025","unstructured":"Liu J, Shen C, Jiang S, Wu Y, Tu J, Bao Y, Li H, Wang N, Liu Y, Xiong J (2025) Deep learning-based tumor segmentation and radiogenomic model for predicting EGFR amplification and assessing intratumoural heterogeneity in glioblastoma. J Big Data 12(1):168","journal-title":"J Big Data"},{"key":"1705_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2023.03.006","author":"J Luo","year":"2023","unstructured":"Luo J, Pan M, Mo K, Mao Y, Zou D (2023) Emerging role of artificial intelligence in diagnosis, classification and clinical management of glioma. Seminars Cancer Biol. https:\/\/doi.org\/10.1016\/j.semcancer.2023.03.006","journal-title":"Seminars Cancer Biol"},{"key":"1705_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fradi.2024.1357341","volume":"4","author":"L Luque","year":"2024","unstructured":"Luque L, Skogen K, MacIntosh BJ, Emblem KE, Larsson C, Bouget D, Helland RH, Reinertsen I, Solheim O, Schellhorn T (2024) Standardized evaluation of the extent of resection in glioblastoma with automated early post-operative segmentation. Front Radiol 4:1357341","journal-title":"Front Radiol"},{"key":"1705_CR59","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/B978-0-443-16034-9.00006-X","volume-title":"Treatment Landscape of Targeted Therapies in Oncology","author":"D Mittal","year":"2023","unstructured":"Mittal D, Verma AK, Singh I (2023) Glioblastoma targeted therapies: updated approaches from recent biological insights. Treatment Landscape of Targeted Therapies in Oncology. Elsevier, pp 135\u2013164"},{"issue":"2","key":"1705_CR60","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11060-022-04080-x","volume":"159","author":"M Moassefi","year":"2022","unstructured":"Moassefi M, Faghani S, Conte GM, Kowalchuk RO, Vahdati S, Crompton DJ, Perez-Vega C, Cabreja RAD, Vora SA, Qui\u00f1ones-Hinojosa A, Parney IF, Trifiletti DM, Erickson BJ (2022) A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients. J Neurooncol 159(2):447\u2013455. https:\/\/doi.org\/10.1007\/s11060-022-04080-x","journal-title":"J Neurooncol"},{"issue":"9","key":"1705_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/nbm.4754","volume":"35","author":"E Moya-S\u00e1ez","year":"2022","unstructured":"Moya-S\u00e1ez E, Navarro-Gonz\u00e1lez R, Cepeda S, P\u00e9rez-N\u00fa\u00f1ez \u00c1, de Luis-Garc\u00eda R, Aja-Fern\u00e1ndez S, Alberola-L\u00f3pez C (2022) Synthetic MRI improves radiomics-based glioblastoma survival prediction. NMR Biomed 35(9):e4754. https:\/\/doi.org\/10.1002\/nbm.4754","journal-title":"NMR Biomed"},{"key":"1705_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1387958","volume":"15","author":"M Mut","year":"2024","unstructured":"Mut M, Zhang M, Gupta I, Fletcher PT, Farzad F, Nwafor D (2024) Augmented surgical decision-making for glioblastoma: integrating AI tools into education and practice. Front Neurol 15:1387958. https:\/\/doi.org\/10.3389\/fneur.2024.1387958","journal-title":"Front Neurol"},{"key":"1705_CR63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejrad.2018.09.017","volume":"108","author":"M Nakagawa","year":"2018","unstructured":"Nakagawa M, Nakaura T, Namimoto T, Kitajima M, Uetani H, Tateishi M, Oda S, Utsunomiya D, Makino K, Nakamura H, Mukasa A, Hirai T, Yamashita Y (2018) Machine learning based on multi-parametric magnetic resonance imaging to differentiate glioblastoma multiforme from primary cerebral nervous system lymphoma. Eur J Radiol 108:147\u2013154. https:\/\/doi.org\/10.1016\/j.ejrad.2018.09.017","journal-title":"Eur J Radiol"},{"key":"1705_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.inffus.2022.01.001","volume":"82","author":"Y Nan","year":"2022","unstructured":"Nan Y, Ser JD, Walsh S, Sch\u00f6nlieb C, Roberts M, Selby I, Howard K, Owen J, Neville J, Guiot J, Ernst B, Pastor A, Alberich-Bayarri A, Menzel MI, Walsh S, Vos W, Flerin N, Charbonnier JP, van Rikxoort E, Chatterjee A, Woodruff H, Lambin P, Cerd\u00e1-Alberich L, Mart\u00ed-Bonmat\u00ed L, Herrera F, Yang G (2022) Data harmonisation for information fusion in digital healthcare: a state-of-the-art systematic review, meta-analysis and future research directions. Inf Fusion 82:99\u2013122. https:\/\/doi.org\/10.1016\/j.inffus.2022.01.001","journal-title":"Inf Fusion"},{"issue":"5","key":"1705_CR65","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/ki.2008.496","volume":"75","author":"EA Neuwelt","year":"2009","unstructured":"Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, Watnick SG (2009) Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int 75(5):465\u2013474. https:\/\/doi.org\/10.1038\/ki.2008.496","journal-title":"Kidney Int"},{"issue":"3","key":"1705_CR66","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","volume":"15","author":"M P\u00e0ez-Ribes","year":"2009","unstructured":"P\u00e0ez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, Vi\u00f1als F, Inoue M, Bergers G, Hanahan D, Casanovas O (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15(3):220\u2013231. https:\/\/doi.org\/10.1016\/j.ccr.2009.01.027","journal-title":"Cancer Cell"},{"issue":"1","key":"1705_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44794-0","volume":"13","author":"HG Pemberton","year":"2023","unstructured":"Pemberton HG, Wu J, Kommers I, M\u00fcller DM, Hu Y, Goodkin O, Vos SB, Bisdas S, Robe PA, Ardon H (2023) Multi-class glioma segmentation on real-world data with missing MRI sequences: comparison of three deep learning algorithms. Sci Rep 13(1):18911","journal-title":"Sci Rep"},{"issue":"1","key":"1705_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-pathmechdis-111523-023417","volume":"20","author":"TM Pentimalli","year":"2025","unstructured":"Pentimalli TM, Karaiskos N, Rajewsky N (2025) Challenges and opportunities in the clinical translation of high-resolution spatial transcriptomics. Annu Rev Pathol 20(1):405\u2013432. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-111523-023417","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"1705_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22739-2","volume":"8","author":"S Rathore","year":"2018","unstructured":"Rathore S, Akbari H, Rozycki M, Abdullah KG, Nasrallah MP, Binder ZA, Davuluri RV, Lustig RA, Dahmane N, Bilello M (2018) Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1. Sci Rep 8(1):5087","journal-title":"Sci Rep"},{"issue":"9\u201310","key":"1705_CR70","first-page":"360","volume":"38","author":"RD Read","year":"2024","unstructured":"Read RD, Tapp ZM, Rajappa P, Hambardzumyan D (2024) Glioblastoma microenvironment from biology to therapy. Genes Dev 38(9\u201310):360\u2013379","journal-title":"Genes Dev"},{"issue":"1","key":"1705_CR71","doi-asserted-by":"publisher","first-page":"27995","DOI":"10.1038\/s41598-024-78189-6","volume":"14","author":"FCF Restini","year":"2024","unstructured":"Restini FCF, Torfeh T, Aouadi S, Hammoud R, Al-Hammadi N, Starling MTM, Sousa CFPM, Mancini A, Brito LH, Yoshimoto FH et al (2024) AI tool for predicting MGMT methylation in glioblastoma for clinical decision support in resource limited settings. Sci Rep 14(1):27995","journal-title":"Sci Rep"},{"issue":"8","key":"1705_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081485","volume":"16","author":"SA Rios","year":"2024","unstructured":"Rios SA, Oyervides S, Uribe D, Reyes AM, Fanniel V, Vazquez J, Keniry M (2024) Emerging therapies for glioblastoma. Cancers 16(8):1485","journal-title":"Cancers"},{"issue":"3","key":"1705_CR73","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1148\/radiol.2018181928","volume":"290","author":"JD Rudie","year":"2019","unstructured":"Rudie JD, Rauschecker AM, Bryan RN, Davatzikos C, Mohan S (2019) Emerging applications of artificial intelligence in neuro-oncology. Radiology 290(3):607\u2013618","journal-title":"Radiology"},{"issue":"5","key":"1705_CR74","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","volume":"1","author":"C Rudin","year":"2019","unstructured":"Rudin C (2019) Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat Mach Intell 1(5):206\u2013215. https:\/\/doi.org\/10.1038\/s42256-019-0048-x","journal-title":"Nat Mach Intell"},{"key":"1705_CR75","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1093\/neuonc\/noab196.897","volume":"23","author":"Z Samani","year":"2021","unstructured":"Samani Z, Riahi D, Parker R, Wolf S, Brem VR (2021a) AI-based biomarker of the peritumoral region using tissue microstructure. Neuro-Oncology 23:223\u2013224","journal-title":"Neuro-Oncology"},{"issue":"1","key":"1705_CR76","doi-asserted-by":"publisher","first-page":"14469","DOI":"10.1038\/s41598-021-93804-6","volume":"11","author":"Z Samani","year":"2021","unstructured":"Samani Z, Riahi D, Parker R, Wolf W, Hodges S, Brem, Verma R (2021b) Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases. Sci Rep 11(1):14469","journal-title":"Sci Rep"},{"issue":"3","key":"1705_CR77","doi-asserted-by":"publisher","DOI":"10.1117\/1.Jmi.8.3.031905","volume":"8","author":"J Santinha","year":"2021","unstructured":"Santinha J, Matos C, Figueiredo M, Papanikolaou N (2021) Improving performance and generalizability in radiogenomics: a pilot study for prediction of IDH1\/2 mutation status in gliomas with multicentric data. J Med Imaging (Bellingham) 8(3):031905. https:\/\/doi.org\/10.1117\/1.Jmi.8.3.031905","journal-title":"J Med Imaging (Bellingham)"},{"issue":"Supplement_6","key":"1705_CR78","doi-asserted-by":"publisher","first-page":"vi223","DOI":"10.1093\/neuonc\/noab196.896","volume":"23","author":"S Shah","year":"2021","unstructured":"Shah S, Manzoor S, Rothman Y, Hagen M, Prater L, Golnik K, Mahammedi A, Lin A, Bhabhra R, Forbes Jonathan (2021) BRMP-03. Pituitary carcinoma: a case of dramatic response to immunotherapy (ipilimumab+ nivolumab) after failure with temozolomide. Neuro-Oncology 23(Supplement_6):vi223\u2013vi223","journal-title":"Neuro-Oncology"},{"issue":"1","key":"1705_CR79","volume":"5","author":"P Sharma","year":"2023","unstructured":"Sharma P, Aaroe A, Liang J, Puduvalli VK (2023) Tumor microenvironment in glioblastoma: current and emerging concepts. Neurooncol Adv 5(1):vdad009","journal-title":"Neurooncol Adv"},{"key":"1705_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12121264","author":"A Stadlbauer","year":"2022","unstructured":"Stadlbauer A, Heinz G, Marhold F, Meyer-B\u00e4se A, Ganslandt O, Buchfelder M, Oberndorfer S (2022) Differentiation of glioblastoma and brain metastases by MRI-based oxygen metabolomic radiomics and deep learning. Metabolites. https:\/\/doi.org\/10.3390\/metabo12121264","journal-title":"Metabolites"},{"issue":"1","key":"1705_CR81","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdad148","volume":"5","author":"J Stoller","year":"2023","unstructured":"Stoller J, Kersch CN, Muldoon LL, Ambady P, Harrington CA, Fu R, Raslan AM, Dogan A, Neuwelt EA, Barajas RF Jr. (2023a) Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes. Neurooncol Adv 5(1):vdad148. https:\/\/doi.org\/10.1093\/noajnl\/vdad148","journal-title":"Neurooncol Adv"},{"issue":"1","key":"1705_CR82","volume":"5","author":"J Stoller","year":"2023","unstructured":"Stoller J, Kersch CN, Muldoon LL, Ambady P, Harrington CA, Fu R, Raslan AM, Dogan A, Neuwelt EA, Barajas RF Jr. (2023b) Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes. Neurooncol Adv 5(1):vdad148","journal-title":"Neurooncol Adv"},{"issue":"1","key":"1705_CR83","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2","volume":"9","author":"T Sugahara","year":"1999","unstructured":"Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, Okuda T, Liang L, Ge Y, Komohara Y, Ushio Y, Takahashi M (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9(1):53\u201360.","journal-title":"J Magn Reson Imaging"},{"key":"1705_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108636","volume":"177","author":"Y Sun","year":"2024","unstructured":"Sun Y, Zhang Y, Gan J, Zhou H, Guo S, Wang X, Zhang C, Zheng W, Zhao X, Li X, Wang L, Ning S (2024) Comprehensive quantitative radiogenomic evaluation reveals novel radiomic subtypes with distinct immune pattern in glioma. Comput Biol Med 177:108636. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108636","journal-title":"Comput Biol Med"},{"issue":"3","key":"1705_CR85","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/rli.0000000000000828","volume":"57","author":"MF Thomas","year":"2022","unstructured":"Thomas MF, Kofler F, Grundl L, Finck T, Li H, Zimmer C, Menze B, Wiestler B (2022) Improving automated glioma segmentation in routine clinical use through artificial intelligence-based replacement of missing sequences with synthetic magnetic resonance imaging scans. Invest Radiol 57(3):187\u2013193. https:\/\/doi.org\/10.1097\/rli.0000000000000828","journal-title":"Invest Radiol"},{"issue":"7","key":"1705_CR86","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/annonc\/mdx106","volume":"28","author":"M Touat","year":"2017","unstructured":"Touat M, Idbaih A, Sanson M, Ligon KL (2017) Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol 28(7):1457\u20131472","journal-title":"Ann Oncol"},{"issue":"1","key":"1705_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01861-2","volume":"8","author":"N Tran","year":"2025","unstructured":"Tran N, Luks TL, Li Y, Jakary A, Ellison J, Liu B, Adegbite O, Nair D, Kakhandiki P, Molinaro AM (2025) Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI. NPJ Digit Med 8(1):508","journal-title":"NPJ Digit Med"},{"key":"1705_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1355242","volume":"15","author":"DK Tripathy","year":"2024","unstructured":"Tripathy DK, Panda LP, Biswal S, Barhwal K (2024) Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches. Front Pharmacol 15:1355242","journal-title":"Front Pharmacol"},{"issue":"12","key":"1705_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/electronics14122498","volume":"14","author":"Y-H Tsai","year":"2025","unstructured":"Tsai Y-H, Cheng W-Y, Huang B-H, Shen C-C, Tsai M-H (2025) Optimizing glioblastoma multiforme diagnosis: semantic segmentation and survival modeling using MRI and genotypic data. Electronics 14(12):2498","journal-title":"Electronics"},{"key":"1705_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/biology11020313","author":"D Uribe","year":"2022","unstructured":"Uribe D, Niechi I, Rackov G, Erices JI, San R, Mart\u00edn, Quezada C (2022) Adapt to persist: glioblastoma microenvironment and epigenetic regulation on cell plasticity. Biology (Basel). https:\/\/doi.org\/10.3390\/biology11020313","journal-title":"Biology (Basel)"},{"issue":"12","key":"1705_CR91","doi-asserted-by":"publisher","first-page":"9638","DOI":"10.1007\/s00330-021-08035-0","volume":"31","author":"EJ van Kempen","year":"2021","unstructured":"van Kempen EJ, Post M, Mannil M, Witkam RL, Laan MT, Patel A, Meijer FJA, Henssen D (2021) Performance of machine learning algorithms for glioma segmentation of brain MRI: a systematic literature review and meta-analysis. Eur Radiol 31(12):9638\u20139653. https:\/\/doi.org\/10.1007\/s00330-021-08035-0","journal-title":"Eur Radiol"},{"key":"1705_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103028","author":"C Walker","year":"2018","unstructured":"Walker C, Mojares E, Del R\u00edo Hern\u00e1ndez A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19103028","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1705_CR93","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s00701-020-04483-7","volume":"162","author":"Y Wan","year":"2020","unstructured":"Wan Y, Rahmat R, Price SJ (2020) Deep learning for glioblastoma segmentation using preoperative magnetic resonance imaging identifies volumetric features associated with survival. Acta Neurochir (Wien) 162(12):3067\u20133080. https:\/\/doi.org\/10.1007\/s00701-020-04483-7","journal-title":"Acta Neurochir (Wien)"},{"issue":"8","key":"1705_CR94","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/neuonc\/noaa106","volume":"22","author":"PY Wen","year":"2020","unstructured":"Wen PY, Weller M, Lee EQ, Alexander BM, Barnholtz-Sloan JS, Barthel FP, Batchelor TT, Bindra RS, Chang SM, Chiocca EA (2020) Glioblastoma in adults: a society for Neuro-Oncology (SNO) and European society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-Oncology 22(8):1073\u20131113","journal-title":"Neuro-Oncology"},{"issue":"1","key":"1705_CR95","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdab174","volume":"3","author":"RT Woodall","year":"2021","unstructured":"Woodall RT, Sahoo P, Cui Y, Chen BT, Shiroishi MS, Lavini C, Frankel P, Gutova M, Brown CE, Munson JM (2021) Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma. Neuro Oncol Adv 3(1):vdab174","journal-title":"Neuro Oncol Adv"},{"key":"1705_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE (2021) Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance. Pharmacol Res 171:105780","journal-title":"Pharmacol Res"},{"issue":"11","key":"1705_CR97","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s00234-024-03451-7","volume":"66","author":"Y-F Yang","year":"2024","unstructured":"Yang Y-F, Zhao E, Shi Y, Zhang H, Yang Y-Y (2024) Multicenter investigation of preoperative distinction between primary central nervous system lymphomas and glioblastomas through interpretable artificial intelligence models. Neuroradiology 66(11):1893\u20131906","journal-title":"Neuroradiology"},{"issue":"1","key":"1705_CR98","doi-asserted-by":"publisher","first-page":"7433","DOI":"10.1038\/s41598-025-90128-7","volume":"15","author":"M Yu","year":"2025","unstructured":"Yu M, Liu J, Zhou W, Gu X, Yu S (2025) MRI radiomics based on machine learning in high-grade gliomas as a promising tool for prediction of CD44 expression and overall survival. Sci Rep 15(1):7433","journal-title":"Sci Rep"},{"key":"1705_CR99","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyaf127","author":"C Zerbib","year":"2025","unstructured":"Zerbib C, Robinet L, Ken S, Cavillon A, Roques M, Larrieu D, Siegfried A, Roux FE, Berjaoui A, Cohen-Jonathan E (2025) Clinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a molecular glioblastoma. Oncologist. https:\/\/doi.org\/10.1093\/oncolo\/oyaf127","journal-title":"Oncologist"},{"key":"1705_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.compmedimag.2025.102628","author":"Z Zhao","year":"2025","unstructured":"Zhao Z, Le NQK, Chin Heng M, Chua (2025) AI-driven multi-modal framework for prognostic modeling in glioblastoma: enhancing clinical decision support. Comput Med Imaging Graph. https:\/\/doi.org\/10.1016\/j.compmedimag.2025.102628","journal-title":"Comput Med Imaging Graph"},{"key":"1705_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109369","volume":"118","author":"W Zhou","year":"2019","unstructured":"Zhou W, Yu X, Sun S, Zhang X, Yang W, Zhang J, Zhang X, Jiang Z (2019) Increased expression of MMP-2 and MMP-9 indicates poor prognosis in glioma recurrence. Biomed Pharmacother 118:109369. https:\/\/doi.org\/10.1016\/j.biopha.2019.109369","journal-title":"Biomed Pharmacother"},{"issue":"24","key":"1705_CR102","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1158\/1078-0432.Ccr-17-3420","volume":"24","author":"PO Zinn","year":"2018","unstructured":"Zinn PO, Singh SK, Kotrotsou A, Hassan I, Thomas G, Luedi MM, Elakkad A, Elshafeey N, Idris T, Mosley J, Gumin J, Fuller GN, de Groot JF, Baladandayuthapani V, Sulman EP, Kumar AJ, Sawaya R, Lang FF, Piwnica-Worms D, Colen RR (2018) A coclinical radiogenomic validation study: conserved magnetic resonance radiomic appearance of Periostin-Expressing glioblastoma in patients and xenograft models. Clin Cancer Res 24(24):6288\u20136299. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-3420","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1705_CR103","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12911-024-02519-x","volume":"24","author":"AMJ Zubair Rahman","year":"2024","unstructured":"Zubair Rahman AMJ, Gupta M, Aarathi S, Mahesh TR, Kumar VV, Kumaran SY, Guluwadi S (2024) Advanced AI-driven approach for enhanced brain tumor detection from MRI images utilizing EfficientNetB2 with equalization and homomorphic filtering. BMC Med Inform Decis Mak 24(1):113","journal-title":"BMC Med Inform Decis Mak"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01705-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01705-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:02:10Z","timestamp":1774076530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01705-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01705-x","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"71"}}